← Toutes les offres
J

Transcript: Building an Early Warning System for Pandemics

jefftk

Global
Publié le 20 novembre 2026

Description du poste

This is an edited transcript of a talk I gave at EAG NYC 2026. I'm Jeff Kaufman, and I lead SecureBio Detection. There's a lot of interest right now in new projects to reduce catastrophic risk, and I thought it would be interesting to look at how the project of SecureBio Detection grew from a concept to a running system. I should warn you up front, I am a very narrative-driven person, and so a lot of this will feel a bit neat, as if stages inexorably flowed together. But the real world is messy and contingent, with key decisions downstream from mistakes, personality conflicts, and luck. There are generalizable insights here, however, and I'm going to see what I can share. I joined the project early on, but wasn't there for the beginning: I can't speak to quite the whole journey. Instead, I'll start by introducing you to these ideas as I first encountered them. I learned about the idea of building a pandemic early warning system on the EA Forum. Andrew Snyder-Beattie, who led (and still leads) Coefficient Giving's biosecurity grant-making program, and Ethan Alley, who at the time was running the vaccine startup Alvea, shared a list of concrete projects to reduce catastrophic biorisk. First on the list was an early detection center. I remember reading about it, and that seemed like an interesting idea. I thought, it would be really good for some people to go work on that. And then I kept scrolling. At the time, I was earning to give at a job I liked. I was pretty content. But then, a few months later, I was talking to some EA friends about whether I could be doing something more valuable, and I realized, actually, biosecurity was a place I could contribute. And as I talked to more people and started to look for biosecurity projects to work on, one that seemed particularly promising was the Nucleic Acid Observatory. Will Bradshaw, Mike McLaren, and Anjali Gopal had founded it within Kevin Esvelt's lab at MIT, and I talked with them, quickly became very excited, a